##Revenue and Profitability##

The company, identified by `C020`, has demonstrated significant revenue growth from Q1 2020 to Q4 2024. Starting with $4,200,000 in revenue in Q1 2020, it increased to $39,800,000 by Q4 2024. This growth is accompanied by a steady improvement in gross profit, which rose from $1,600,000 in Q1 2020 to $19,300,000 in Q4 2024. The gross margin percentage also saw a positive trend, climbing from 38.1% in Q1 2020 to 48.5% in Q4 2024. Most recently, in Q2 2025, the company reported revenue of $21,800,000 and a gross profit of $10,700,000, with a gross margin of 49.1%.

##Operating Expenses and Income##

Operating expenses (opex) for `C020` have also increased over the periods, from $2,800,000 in Q1 2020 to $10,200,000 in Q4 2024. This increase in opex is driven by rising research and development (R&D) expenses, selling expenses, and administrative expenses. Despite the growth in operating expenses, the company has transitioned from an operating loss of $1,200,000 in Q1 2020 to a substantial operating income of $9,100,000 in Q4 2024. In Q2 2025, operating income stood at $5,100,000 with operating expenses at $5,600,000.

##Net Income and Earnings Per Share##

The company's financial performance has seen a dramatic turnaround in terms of net income. From a net loss of $1,230,000 in Q1 2020 with a basic EPS of -0.18, `C020` achieved a net income of $8,870,000 in Q4 2024, with a basic EPS of $0.87. This positive trend continued into Q2 2025, with a net income of $4,963,000 and a basic EPS of $0.49. Interest expense has remained relatively low and stable throughout these periods, while tax expenses have generally increased in line with profitability.

##Cash Flow and Liquidity##

Free cash flow (FCF) has shown a significant positive trajectory, increasing from a negative $850,000 in Q1 2020 to a positive $2,200,000 in Q4 2024. This indicates improved cash generation from operations after accounting for capital expenditures. The company's cash and equivalents have also grown from $2,100,000 in Q1 2020 to $4,200,000 in Q4 2024, and $4,400,000 in Q2 2025, suggesting a healthy liquidity position.

##Assets and Liabilities##

Total assets for `C020` have grown consistently, reaching $15,800,000 in Q4 2024 from $8,200,000 in Q1 2020. This asset growth is supported by increases in accounts receivable, inventory, and property, plant, and equipment. Consequently, total liabilities have also increased, from $3,300,000 in Q1 2020 to $4,800,000 in Q4 2024. However, the growth in shareholders' equity has outpaced the growth in liabilities, with shareholders' equity rising from $4,900,000 in Q1 2020 to $11,000,000 in Q4 2024 and $11,500,000 in Q2 2025. This indicates a strengthening financial position and an increasing equity base.
